Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,108 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,158)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04502095 | Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy | completed | Phase 4 | 89 | Roswell Park Cancer InstituteOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT04145518 | Mechanistic Characterization of Uterine Pain(MCUP) | completed | Phase 4 | 183 | Endeavor HealthOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT00904410 |
| Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET(CHIMTEP) |
| completed |
| Phase 4 |
| 63 |
| Centre Oscar LambretOTHER |
| 1 |
| Sep 17, 2026 |
| clinicaltrials |
| NCT00911092 | Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer(COL) | completed | Phase 4 | 50 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05206331 | CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study | completed | Phase 4 | 2,089 | Margarita Louise ZuleyOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06285370 | A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy | completed | Phase 4 | 23 | Kyowa Kirin China Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 9, 2026 | clinicaltrials |
| NCT04016376 | Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction | completed | Phase 4 | 1,507 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07773909 | Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy | completed | Phase 4 | 24 | Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT05562518 | GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.(GRACE) | completed | Phase 4 | 31 | University Hospital, GhentOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT00333099 | INEC Study: Immuno-modulating Enteral Nutrition in Cancer | completed | Phase 4 | 250 | University Hospital, Clermont-FerrandOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07743333 | Nebulized Lidocaine And Ketamine Before Fiberoptic Bronchoscopy | completed | Phase 4 | 134 | Alexandria UniversityOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT04846855 | Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric Population(RATAPED) | completed | Phase 4 | 100 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06035757 | The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery | completed | Phase 4 | 76 | Konkuk University Medical CenterOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT02422745 | COcoa Supplement and Multivitamin Outcomes Study(COSMOS) | completed | Phase 4 | 21,442 | Brigham and Women's HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06604442 | Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy | completed | Phase 4 | 62 | Blue Earth DiagnosticsINDUSTRY | 1 | Jul 13, 2026 | clinicaltrials |
| NCT05631795 | Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment(ALPINIST) | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT05365230 | A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer | completed | Phase 4 | 261 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT03664687 | Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)(REaCT-ZOL) | completed | Phase 4 | 211 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT04246697 | Multimodal Pain Study in Free Flap Patients | completed | Phase 4 | 30 | University of Kansas Medical CenterOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT03641560 | A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy | completed | Phase 4 | 52 | Astellas Pharma IncINDUSTRY | 1 | Jun 24, 2026 | clinicaltrials |
| NCT00771199 | An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain | completed | Phase 4 | 14 | Janssen-Cilag Ltd.INDUSTRY | 1 | Jun 4, 2026 | clinicaltrials |
| NCT04764292 | Screening Contrast-Enhanced Mammography as an Alternative to MRI(SCEMAM) | completed | Phase 4 | 615 | Wendie BergOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT03610022 | Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1(OPTIVISMO-1) | completed | Phase 4 | 27 | University Hospital, BordeauxOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT03934684 | Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma | completed | Phase 4 | 101 | AmgenINDUSTRY | 1 | May 11, 2026 | clinicaltrials |
| NCT04745910 | Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome | completed | Phase 4 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06625047 | Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy | completed | Phase 4 | 30 | Mayo ClinicOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT01553903 | Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not(OXYTAM) | completed | Phase 4 | 29 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01612871 | Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer(MIRHO) | completed | Phase 4 | 39 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT03514381 | Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma(IPIAP-STM) | completed | Phase 4 | 59 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05110196 | Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC. | completed | Phase 4 | 50 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 7, 2026 | clinicaltrials |
| NCT02555748 | Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma(SUP-R) | completed | Phase 4 | 47 | Institut Claudius RegaudOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07487129 | Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt(Clinical and P) | completed | Phase 4 | 206 | Beni-Suef UniversityOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT03151213 | Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver(pregabalin) | completed | Phase 4 | 70 | Sherief Abd-ElsalamOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT04024254 | A Study of Serum Folate Levels in Patients Treated With Olaparib | completed | Phase 4 | 10 | Rush University Medical CenterOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT03348969 | Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC(NICSA) | completed | Phase 4 | 120 | Jørgen Bjerggaard JensenOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT04288323 | Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis | completed | Phase 4 | 79 | University of California, San DiegoOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT02844309 | The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM(BDH-WM02) | completed | Phase 4 | 44 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT02844322 | The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia(BDH-WM01) | completed | Phase 4 | 35 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT02844361 | Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia(BDH-WM03) | completed | Phase 4 | 70 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT02858804 | EDOCH Alternating With DHAP for New Diagnosed Younger MCL(BDH-MCL01) | completed | Phase 4 | 55 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT04474821 | HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults | completed | Phase 4 | 100 | Mayo ClinicOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT04864405 | Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance | completed | Phase 4 | 245 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT07022938 | Nutritional Supplement for Treating Chemotherapy Induced Neuropathy | completed | Phase 4 | 71 | Aristotle University Of ThessalonikiOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT04952766 | Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults(EREVA) | completed | Phase 4 | 196 | Centre Hospitalier Régional d'OrléansOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT02651948 | Transperineal, MRI-guided, Prostate Biopsy | completed | Phase 4 | 90 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT02696707 | An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer(OTT 15-05) | completed | Phase 4 | 200 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT05222464 | Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility Study | completed | Phase 4 | 56 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT05687032 | A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | completed | Phase 4 | 44 | PfizerINDUSTRY | 1 | Dec 3, 2025 | clinicaltrials |
| NCT03963206 | Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)(CLERANCE) | completed | Phase 4 | 110 | Hospices Civils de LyonOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT05511428 | Home Based Daratumumab Administration for Patients With Multiple Myeloma | completed | Phase 4 | 20 | Thomas Jefferson UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
Data updated 11 hours agoSource updated Sep 29, 2026source: clinicaltrials